In a move sparking fierce debate across Sweden’s medical community, the National Board of Health and Welfare (Socialstyrelsen) has opted to maintain the current starting age for national bowel cancer screening at 60 — despite mounting international pressure and alarming new data showing rising cancer rates among younger adults.
The European Union’s latest cancer screening guidelines, updated in 2023, recommend initiating colorectal cancer screening at age 50 — a standard already adopted by countries including Germany, the Netherlands, and the United Kingdom. But Sweden’s top health authority has dug in its heels, citing concerns over healthcare resource allocation and a lack of projected mortality reduction from earlier screening.
Doctors aren’t buying it.
“This decision is dangerously out of step with reality,” says Dr. Lena Bergström, a gastroenterologist at Karolinska University Hospital and spokesperson for the Swedish Society of Gastroenterology. “We’re seeing more and more patients in their 40s — even late 30s — diagnosed with advanced colon and rectal cancers. By the time symptoms appear, it’s often too late. Screening saves lives. Delaying it until 60 ignores the data and endangers patients.”
Her frustration is echoed across the country. A 2023 national cancer registry report revealed a 47% increase in colorectal cancer diagnoses among Swedes under 50 over the past decade — a trend consistent with global patterns. In the U.S., similar spikes prompted the Centres for Disease Control and Prevention (CDC) to lower its screening recommendation to 45 in 2021.
Yet Sweden’s National Board insists its stance is scientifically grounded. In a statement released last week, the agency argued that “current modelling does not indicate a significant reduction in overall mortality from lowering the screening age,” and warned that expanding the program “would require diverting resources from other critical areas of care — including breast and cervical cancer screening, mental health services, and paediatric care.”
Critics call that reasoning short-sighted.
“It’s a false economy,” argues Dr. Erik Nilsson, oncologist at Sahlgrenska University Hospital. “Yes, screening more people costs more upfront. But treating late-stage cancer? That’s exponentially more expensive — not to mention the human cost. We’re talking about preventable deaths.”
The Board’s reliance on “older studies” has also drawn fire. Much of its analysis reportedly draws from data collected before 2020 — prior to the documented surge in early-onset cases. Medical professionals argue that public health policy must evolve with epidemiological trends, not lag behind them.
“Medicine isn’t static,” says Dr. Bergström. “If the data changes, the guidelines must change. That’s not opinion — that’s science.”
Patient advocacy groups have joined the chorus. “Emma’s Story,” a campaign launched by the family of 48-year-old Emma Lindqvist — who died of stage IV colon cancer in 2024 after being told she was “too young to screen” — has gained over 50,000 signatures on a petition urging the government to override the Board’s recommendation.
The controversy also raises broader questions about Sweden’s healthcare prioritisation model. While the country consistently ranks high in global health indices, its centralised decision-making can sometimes slow adaptation to emerging threats.
“We pride ourselves on evidence-based medicine,” says Dr. Nilsson. “But when the evidence screams for change and we don’t listen? That’s not caution — that’s negligence.”
As pressure mounts, the National Board says it will “continue to monitor the situation” and “review new data as it emerges.” But for many doctors and patients, that’s not enough.
“We’re not asking for perfection,” says Dr. Bergström. “We’re asking for parity with Europe — and for our younger patients to have the same chance at early detection that their parents and grandparents had.”
For now, Swedes under 60 concerned about bowel cancer must either pay out-of-pocket for private screening or hope their symptoms appear early enough for successful intervention.
In a nation known for progressive healthcare, many are asking: Why is Sweden waiting for more lives to be lost before it acts?
If you’re under 60 and experiencing symptoms such as persistent changes in bowel habits, blood in stool, unexplained weight loss, or abdominal pain, consult your doctor immediately — don’t wait for a national screening invitation.